Drawing for SIGNATERA

USPTO serial 87744038

SIGNATERA

Reviewed by CopyMark Law Group

Reg. 5997557Status 702Registered
Filing date
Status date
Registration date
Feb 25, 2020
Examiner
ROSSMAN, WILLIAM M
Law office
Historical data usage

What this means

Status 702 means the registration is active, Section 8 was accepted, and a Section 15 declaration of incontestability was also accepted. Incontestability strengthens your rights by limiting certain challenges after five years of continuous use. Continue use in commerce and plan for the 10-year Section 8 and 9 renewal.

Status 702: Status 702 means the registration is active, Section 8 was accepted, and a Section 15 declaration of incontestability was also accepted. Incontestability strengthens your rights by limiting certain challenges after five years of continuous use.

Need help with SIGNATERA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Tricia L. Schulz

Tricia L. Schulz FOLEY & LARDNER LLP150 EAST GILMAN STREET, SUITE 5000MADISON, WI 53703-1481United States

Goods and services

ClassDescriptionStatusFirst use
005Reagents for medical use; medical diagnostic reagents; genetic tests comprised of reagents for medical purposesACTIVEMay 23, 2019
010Blood collection kit comprised of blood collecting tubesACTIVEMay 23, 2019
042Medical and scientific research and analysis in the field of genetic testing; providing medical and scientific research information in the field of genetic testing; medical laboratory services; genetic testing for scientific research and analysis purposes; genetic testing for scientific research and analysis purposes in the field of human reproduction; providing a website featuring information in the field of genetic testing for scientific purposesACTIVEAug 21, 2017
044Genetic testing for medical purposes; genetic counseling; genetic testing for medical purposes and genetic counseling in the field of human reproduction; providing a website featuring information about genetic testing for medical purposes and genetic counselingACTIVEMay 23, 2019

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jun 23, 2026NA85NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED—
Jun 23, 2026C15AREGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.—
May 18, 2026APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Feb 24, 2026E815TEAS SECTION 8 & 15 RECEIVED—
Feb 25, 2025REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Jun 9, 2021NOSUNOTICE OF SUIT—
Feb 25, 2020R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jan 21, 2020SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED—
Jan 19, 2020CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
Dec 28, 2019EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Dec 27, 2019SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Dec 27, 2019EX3GSOU EXTENSION 3 GRANTED—
Dec 26, 2019AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Dec 17, 2019IUAFUSE AMENDMENT FILED—
Dec 17, 2019EXT3SOU EXTENSION 3 FILED—
Dec 17, 2019EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Dec 17, 2019EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Jul 17, 2019EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jul 15, 2019EX2GSOU EXTENSION 2 GRANTED—
Jul 15, 2019EXT2SOU EXTENSION 2 FILED—
Jul 15, 2019EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Dec 28, 2018EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Dec 26, 2018EX1GSOU EXTENSION 1 GRANTED—
Dec 26, 2018EXT1SOU EXTENSION 1 FILED—
Dec 26, 2018EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jul 17, 2018NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
May 22, 2018NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
May 22, 2018PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
May 2, 2018NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Apr 13, 2018CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Apr 13, 2018DOCKASSIGNED TO EXAMINER—
Jan 19, 2018NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jan 8, 2018NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance